Near-infrared fluorescence imaging-guided surgery improves recurrence-free survival rate in novel orthotopic animal model of head and neck squamous cell carcinoma

Near-infrared fluorescence imaging-guided surgery improves recurrence-free survival rate in novel orthotopic animal model of head and neck squamous cell carcinoma
复制标题

DOI:
10.1002/hed.23980
复制
发表时间:
2016-04-01
影响因子:
2.9
通讯作者:
Righini, Christian Adrien
Righini, Christian Adrien
中科院分区:
医学2区
文献类型:
--
作者:
Atallah, Ihab;Milet, Clement;Righini, Christian Adrien

文献摘要

被引文献

相似文献

背景资料。需要合适的动物模型来测试头颈部鳞状细胞癌(HNSCC)的新治疗方法,如近红外(NIR)成像引导手术。我们建立了一种最佳的原位HNSCC动物模型(在雌性裸鼠体内),延长了存活时间。植入后30天,在使用或不使用小型临床级近红外光学成像设备的辅助下,在系统地注射以α(V)β(3)整合素为靶点的基于RGD的荧光探针后,对原位肿瘤进行切除。NIR光学成像引导手术通过检测微小到185 mm的荧光癌残留物,使复发生存率提高了50%;如果完全在无辅助视觉引导下进行切除,这些残留物可能仍然无法识别。近红外光学成像引导手术显示,在我们优化的原位动物模型中,HNSCC肿瘤切除质量得到了改善。(C)2015年威利期刊公司。
Background. Appropriate animal models are required to test novel therapeutics for head and neck squamous cell carcinoma (HNSCC) such as near-infrared (NIR) imaging-guided surgery.Methods. We developed an optimized animal model of orthotopic HNSCC (in female athymic NMRI (Naval Medical Research Institute) nude mice) with a prolonged survival time. Resection of the orthotopic tumors was performed 30 days after implantation with or without the aid of a miniaturized clinical grade NIR optical imaging device, after systemic administration of a fluorescent RGD-based probe that targets alpha(v)beta(3) integrin.Results. NIR optical imaging-guided surgery increased the recurrencefree survival rate by 50% through the detection of fluorescent cancer residues as small as 185 mm; these fragments could remain unidentified if resection was performed exclusively under unaided visual guidance.Conclusion. NIR optical imaging-guided surgery showed an improved HNSCC tumor resection quality in our optimized orthotopic animal model. (C) 2015 Wiley Periodicals, Inc.